First Time Loading...

HLS Therapeutics Inc
TSX:HLS

Watchlist Manager
HLS Therapeutics Inc Logo
HLS Therapeutics Inc
TSX:HLS
Watchlist
Price: 4.65 CAD Market Closed
Updated: May 3, 2024
Section:
 

Relative Value

The Relative Value of one HLS stock under the Base Case scenario is 14.8 CAD. Compared to the current market price of 4.65 CAD, HLS Therapeutics Inc is Undervalued by 69%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HLS Relative Value
Base Case
14.8 CAD
Undervaluation 69%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.7
P/S
P/S
Price to Sales
1.7
vs History
87
vs Industry
54
Median 3Y
3.8
Median 5Y
6
Industry
2.4
Forward
1.7
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-10.9
Median 5Y
-16.9
Industry
23.2
Forward
-6.2
More Details
6.9
P/OCF
P/OCF
Price to OCF
6.9
vs History
87
vs Industry
44
Median 3Y
13.7
Median 5Y
16.3
Industry
15.5
More Details
17.7
P/FCFE
P/FCFE
Price to FCFE
17.7
vs History
34
vs Industry
27
Median 3Y
14.2
Median 5Y
14.8
Industry
23.5
More Details
1.1
P/B
P/B
Price to Book Value
1.1
vs History
84
vs Industry
61
Median 3Y
1.9
Median 5Y
2.1
Industry
2.2
More Details
2.7
EV/S
EV/S
Enterprise Value to Sales
2.7
vs History
88
vs Industry
42
Median 3Y
4.8
Median 5Y
6.7
Industry
2.5
Forward
2.6
More Details
3.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.1
vs History
85
vs Industry
60
Median 3Y
5.2
Median 5Y
7.1
Industry
5.2
More Details
8.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
8.4
vs History
87
vs Industry
38
Median 3Y
14.1
Median 5Y
14.9
Industry
12.5
Forward
8.3
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-25.2
Median 5Y
-36.1
Industry
17.2
Forward
-13.5
More Details
10.7
EV/OCF
EV/OCF
Enterprise Value to OCF
10.7
vs History
84
vs Industry
37
Median 3Y
17.4
Median 5Y
18.4
Industry
15.1
More Details
10.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
10.9
vs History
63
vs Industry
34
Median 3Y
12.1
Median 5Y
13
Industry
19.7
More Details
1
EV/IC
EV/IC
Enterprise Value to IC
1
vs History
84
vs Industry
61
Median 3Y
1.4
Median 5Y
1.5
Industry
2
More Details

Multiples Across Competitors

HLS Competitors Multiples
HLS Therapeutics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
HLS Therapeutics Inc
TSX:HLS
148.7m CAD 1.7 -4 8.4 -14.3
US
Mckesson Corp
NYSE:MCK
69.5B USD 0.2 23 16.1 18.7
US
Cencora Inc
NYSE:COR
44.8B USD 0.2 24 12.3 17.3
US
Amerisourcebergen Corp
NYSE:ABC
35.4B USD 0.1 20.9 11.3 15.2
US
Cardinal Health Inc
NYSE:CAH
25.1B USD 0.1 39.3 8.8 11.8
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW 5.9 89.6 59.9 61.9
US
Henry Schein Inc
NASDAQ:HSIC
8.9B USD 0.7 21.3 11.3 15.2
CN
Huadong Medicine Co Ltd
SZSE:000963
57.6B CNY 1.4 21.3 15.5 15.5
CN
Sinopharm Group Co Ltd
HKEX:1099
61.2B HKD 0.1 6.3 1.5 1.8
IT
Amplifon SpA
MIL:AMP
7.2B EUR 3.2 46.6 15 29.6
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
51B CNY 0.2 13.5 8 8

See Also

Summary
HLS intrinsic value, competitors valuation, and company profile.
DCF Valuation
HLS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HLS stock valuation using valuation multiples.
Wall Street Estimates
HLS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HLS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.